Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate release
Authors:
- J.D. MikkelsenJMJ.D. Mikkelsen
- J.P. BrunoJBJ.P. Bruno
- 1 December 2013
- journal article
- Published by Elsevier in Neuroscience
- Vol. 255, 55-67
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantaminePsychopharmacology, 2011
- Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of SchizophreniaNeuropsychopharmacology, 2011
- Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortexJournal of Neurochemistry, 2010
- Second‐by‐second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake ratsSynapse, 2009
- The Construct of Attention in SchizophreniaBiological Psychiatry, 2008
- Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophreniaSchizophrenia Research, 2008
- Rats and humans paying attention: Cross-species task development for translational research.Neuropsychology, 2008
- Chronic second‐by‐second measures of l‐glutamate in the central nervous system of freely moving ratsJournal of Neurochemistry, 2007
- The α7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the ratNeuroscience Letters, 2007
- Pharmacologic Aspects of Cigarette Smoking and Nicotine AddictionNew England Journal of Medicine, 1988